Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
445 Views
Emedinexus 15 November 2024
The FDA has approved Rezdiffra for adults with noncirrhotic non-alcoholic steatohepatitis (NASH) and moderate to advanced liver scarring, to be used alongside diet and exercise.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}